AB Discovery Growth Fund, Inc. - Class A
CHCLX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- AllianceBernstein LP New York NY United States of America 10105
- IPO Date
- Jan 2, 1986
- CIK
- 0000019614
- Website
- alliancebernstein.com
- Similar Companies
- Business
- AB Discovery Growth Fund, Inc. - Class A (CHCLX) is a closed-end management investment trust managed by AllianceBernstein L.P., focusing on long-term capital appreciation through equity investments primarily in growth-oriented companies. The fund invests in a diversified portfolio of common stocks, preferred stocks, convertible securities, warrants, and other equity-linked instruments; it emphasizes small- and mid-cap growth stocks across sectors such as technology, healthcare, consumer discretionary, and industrials, with holdings typically featuring companies exhibiting high earnings growth potential, innovative business models, and strong competitive advantages. Geographic operations span U.S. domestic markets with selective international exposure, targeting institutional and retail investors seeking growth equity exposure; the fund was established prior to 2000 and is headquartered in New York, New York, as part of the broader AllianceBernstein family of funds with no notable subsidiaries or parent company beyond its manager. The fund offers share classes including Class A with a front-end sales load, alongside institutional and advisor classes; services include professional portfolio management, daily liquidity via exchange trading (though as a closed-end fund, it trades at a premium or discount to net asset value), and periodic distributions from capital gains or income. It employs a bottom-up fundamental analysis approach, utilizing quantitative screens and qualitative assessments to select securities with superior growth prospects relative to peers. No recent major partnerships, acquisitions, funding rounds, or name changes have been reported in the last 1-2 years; however, the fund has maintained its investment strategy amid market volatility, with portfolio managers adjusting allocations to capitalize on sectors like artificial intelligence and biotechnology amid 2024-2025 economic shifts.